Orion, FI0009014377

Orion stock softens after recent drop but fundamentals stay solid

Published on 09/09/2026 at 19:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Orion stock closed at EUR 79.20 on September 8, 2026 on its Helsinki home exchange, modestly below the 52-week high of EUR 82.80. Recent half-year figures and analyst targets give investors a clearer view of the Finnish pharma group’s outlook.

Moderne Pharmaproduktionsanlage bei Tageslicht, Orion Oyj FI0009014377
Fotorealistisches Bild zeigt moderne Pharmafabrik von Orion Oyj, ISIN FI0009014377, mit Produktionsanlagen in Finnland, Illustration mit AI erstellt.

Orion stock (ISIN FI0009014377) closed at EUR 79.20 on its Helsinki home exchange on September 8, 2026, down 0.94% from the previous session and modestly below the 52-week high of EUR 82.80 as investors digested recent results and analyst views.

Stock holds near its recent highs

According to Yahoo Finance, Orion shares finished trading at EUR 79.20 on September 8, 2026, after opening at EUR 79.65 and moving in a narrow intraday range between EUR 78.75 and EUR 79.85 on the Helsinki exchange.

The same overview shows a 52-week range between a low of EUR 56.50 and a high of EUR 82.80, meaning the current price sits roughly one third above the low and only a few euros below the peak, underlining that the stock remains close to its upper trading band over the past year.

Recent results frame the investment case

Orion is a Finnish pharmaceutical and diagnostics group that reports its figures in euro and is followed closely by the Nordic market; the most recent half-year report for 2026 highlighted growth in prescription drugs and specialty products, giving investors a clearer picture of revenue momentum and profitability in the current year.

Per the company’s investor information, Orion’s latest interim figures for the first half of 2026 showed revenue increasing compared with the prior-year period, while operating profit and margin remained solid against the 2025 baseline, confirming that the business is expanding from its historical revenue level even as costs and investments rise.

For investors, the quantified comparison between present and historical figures matters: the half-year update indicates that revenue for the latest reported period exceeded the level recorded in the corresponding 2025 half-year, and that operating profitability held up rather than falling back to the historical 2024 margin range, a sign of resilient performance in a competitive market.

Analyst targets point to a balanced picture

The current market view of Orion stock is also shaped by analyst price targets and recommendations. According to the analyst overview on Yahoo Finance, the one-year target price for Orion stands at EUR 76.67, with individual targets ranging from a low of EUR 55.00 to a high of EUR 86.00 as of September 8, 2026.

That spectrum of targets means the current closing price of EUR 79.20 is slightly above the average analyst target but still below the most optimistic scenario, while sitting well above the cautious low estimate, which illustrates a market that prices in solid fundamentals but questions how much further upside the shares offer beyond their recent 52-week high area.

The recommendation breakdown in the same analyst snapshot shows a spread across categories from Strong Buy to Sell, signaling that institutions are divided on the near-term risk-return profile; for retail investors this mix underscores that Orion is viewed neither as a clear defensive safe haven nor as an unloved contrarian play.

Stock price and trading data

As of the close on September 8, 2026, Orion stock traded at EUR 79.20 on the Helsinki exchange, compared with a previous close of EUR 79.95, implying a daily decline of 0.94% on moderate price movement within the day’s range of EUR 78.75 to EUR 79.85.

Orion stock key data

  • Company: Orion Corporation
  • ISIN: FI0009014377
  • Ticker: ORNBV.HE
  • Trading venue: Helsinki Stock Exchange
  • Price (as of September 8, 2026, 6:29): 79.20 EUR
  • Market capitalization: [value] EUR (as of September 8, 2026)
  • Sector / Industry: Pharmaceuticals
  • Index membership: OMX Helsinki

More news and analyses on Orion stock

Disclaimer...

en | FI0009014377 | ORION | boerse | 70077310 | bgmi